These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8862939)

  • 1. The value of nifedipine in the treatment of hypertension, coronary heart disease and myocardial infarction (post-infarction therapy).
    Schulz J; Schmidt J; Rück W
    Curr Med Res Opin; 1996; 13(7):397-408. PubMed ID: 8862939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What, if anything, is controversial about calcium antagonists?
    Messerli FH
    Am J Hypertens; 1996 Dec; 9(12 Pt 2):177S-181S. PubMed ID: 8968430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
    Głuszek J; Pawlaczyk-Gabriel K
    Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
    Ishikawa K; Nakai S; Takenaka T; Kanamasa K; Hama J; Ogawa I; Yamamoto T; Oyaizu M; Kimura A; Yamamoto K; Yabushita H; Katori R
    Circulation; 1997 May; 95(10):2368-73. PubMed ID: 9170398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are calcium antagonists cardioprotective?
    Kendall MJ; Horton RC
    J R Coll Physicians Lond; 1985 Apr; 19(2):85-9. PubMed ID: 3889321
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of nifedipine therapy for refractory angina pectoris.
    Stone PH; Turi ZG; Muller JE
    Am Heart J; 1982 Sep; 104(3):672-81. PubMed ID: 6126113
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of action of calcium-channel-blocking agents.
    Braunwald E
    N Engl J Med; 1982 Dec; 307(26):1618-27. PubMed ID: 6292718
    [No Abstract]   [Full Text] [Related]  

  • 10. Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension.
    Tijssen JG; Hugenholtz PG
    Eur Heart J; 1996 Aug; 17(8):1152-7. PubMed ID: 8869855
    [No Abstract]   [Full Text] [Related]  

  • 11. Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction.
    Jonas M; Goldbourt U; Boyko V; Mandelzweig L; Behar S; Reicher-Reiss H
    Cardiovasc Drugs Ther; 1998 May; 12(2):177-81. PubMed ID: 9652876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blocker debate: true lies?
    Leor J; Battler A
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):413-5. PubMed ID: 8924054
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-channel blockers in ischemic heart disease.
    Silvestry FE; Kimmel SE
    Curr Opin Cardiol; 1996 Jul; 11(4):434-9. PubMed ID: 8879955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers and mortality in elderly patients with myocardial infarction.
    Jollis JG; Simpson RJ; Chowdhury MK; Cascio WE; Crouse JR; Massing MW; Smith SC
    Arch Intern Med; 1999 Oct; 159(19):2341-8. PubMed ID: 10547174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary and tertiary prevention with calcium antagonists in coronary artery disease.
    Burkart F
    Drugs; 1992; 43 Suppl 1():37-42. PubMed ID: 1378787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists in the treatment of individuals with ischemic heart disease.
    Winniford MD; Willerson JT; Hillis LD
    Angiology; 1982 Aug; 33(8):522-39. PubMed ID: 6287889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
    Leitch JW; McElduff P; Dobson A; Heller R
    J Am Coll Cardiol; 1998 Jan; 31(1):111-7. PubMed ID: 9426027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The coronary hypertensive: therapeutic principles].
    Gosse P; Aouizerate E; Roudaut R; Dallocchio M
    Ann Cardiol Angeiol (Paris); 1986; 35(7):397-401. PubMed ID: 2879503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine in myocardial ischemia, systemic hypertension, and other cardiovascular disorders.
    Ferlinz J
    Ann Intern Med; 1986 Nov; 105(5):714-29. PubMed ID: 3532894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.